Royalty Pharma invests in a portfolio of drugs, from blockbusters to those still in development.
In the stock market, there are companies that tend to attract attention when the economy is good, and others that attract ...
Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this year. And it's hardly alone – the sector is on a roll and looks poised for more gains.
US biotech Atalanta Therapeutics has come out of stealth mode backed with $110m from Biogen and Roche, who have also signed separate partnerships to develop new therapies for neurological diseases ...
The move pushes Antogen's laboratory footprint beyond the state of California for the first time, the outlet notes. Antogen ...
The U.S. must attract the most talented foreign academics and researchers, but it cannot open its doors to students with ...
Friday, Bolt Biotherapeutics, Inc. (BOLT) announced its acquisition of Prana Therapies, Inc. through a stock-for-stock transaction aimed at advancing Prana's pipeline of half-life-extended ...
AI-enabled cloud, HPC and federated learning accelerate discovery, clinical trials and RWE integration, while precision medicine, multiomics and pharma partnerships drive opportunities.Dublin, Oct.
Discover how omics is transforming life sciences with expert insights from Dr. Shi-Qi An on multiomics, single-cell research ...
Budding biotechnology entrepreneurs now have a new way to connect with the strategic and financial resources and expertise ...
The Discovery and Innovation Center will bring together about 250 faculty members, researchers, postdoctoral fellows and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results